Vitiligo — managed by dermatologists, not stigma
A non-contagious autoimmune condition affecting 1–2% of India's population, treated with evidence-based phototherapy, medical therapy, and surgical techniques at DermaVue's 7 clinics across Kerala & Tamil Nadu.
7 clinics · Kerala & Tamil Nadu · ₹300 consultation
Understanding Vitiligo
Vitiligo occurs when the immune system attacks melanocytes — the cells that produce skin pigment — causing well-defined white patches on the skin. In India, where most people have Fitzpatrick IV–VI skin tones, the contrast between affected and unaffected skin is especially visible, often leading to significant social stigma and psychological distress. Vitiligo is not contagious, not caused by diet, and not a sign of any internal disease. DermaVue dermatologists combine targeted phototherapy, immunomodulatory medications, and surgical melanocyte transfer techniques to stabilise the disease and restore pigment — tailored to each patient's disease stage, body site, and skin type.
Vitiligo is an acquired, chronic depigmentation disorder characterised by selective destruction of epidermal melanocytes, resulting in well-circumscribed, chalk-white macules and patches. Pathogenesis involves a convergence of autoimmune (CD8+ T-cell–mediated cytotoxicity), oxidative stress (elevated H2O2 and reduced catalase activity), neural, and genetic mechanisms.[1] The autoimmune model is supported by association with thyroid autoimmunity, type 1 diabetes mellitus, and pernicious anaemia. Clinically subtyped as non-segmental (generalised, acrofacial, universal) and segmental (dermatomal distribution, earlier onset, rapid stabilisation). Indian Fitzpatrick IV–VI skin phenotypes exhibit higher cosmetic impact and psychosocial burden due to stark contrast between depigmented and normally pigmented skin, necessitating aggressive repigmentation strategies including NB-UVB phototherapy, topical calcineurin inhibitors, and surgical non-cultured epidermal cell suspension (NCES) grafting.[2]
What does Vitiligo look like?
Symptoms range widely in severity. Identifying which type you have determines the right treatment.
White Patches on Skin
Symmetrical Distribution
Koebner Phenomenon
Leukotrichia (White Hair)
Mucosal Involvement
Acrofacial Predilection
Rapid Spread (Progressive Phase)
Sunburn Sensitivity
What actually causes Vitiligo?
Multiple factors act together — understanding them helps prevent recurrence after treatment.
Autoimmune Melanocyte Destruction
Genetic Susceptibility
Oxidative Stress
Neural Hypothesis (Segmental)
Sunburn & Skin Trauma
Psychological Stress
Chemical Exposure
- 1–2% of the Indian population is affected — India has one of the highest reported prevalence rates globally, with some community studies showing up to 8.8% in parts of Rajasthan and Gujarat
- 50% of cases begin before age 20, with a second peak in early adulthood — early intervention significantly improves repigmentation outcomes
- Fitzpatrick IV–VI skin (the majority of South Indian population) shows stark contrast between depigmented and normal skin, amplifying cosmetic and psychosocial impact
- Kerala-specific: high prevalence of autoimmune thyroid disease in the state compounds vitiligo risk; rubber plantation workers face chemical leukoderma exposure from phenolic compounds in rubber processing
- Social stigma in India remains a major burden — vitiligo is wrongly conflated with leprosy in some communities, affecting marriage prospects, employment, and mental health despite the condition being entirely non-contagious
What happens at your DermaVue consultation?
A structured clinical assessment — not a quick glance and a prescription pad. Here's exactly what to expect.
Clinical Examination & History
Wood's Lamp Examination
Dermoscopy & Trichoscopy
Autoimmune & Thyroid Screening
Disease Activity Assessment & Plan
Vitiligo treatments we offer
All procedures by board-certified MD DVL dermatologists. US-FDA approved equipment. No technician-only protocols — ever.
NB-UVB Phototherapy
Targeted Excimer Laser (308 nm)
Topical Immunomodulators
Oral Mini-Pulse Therapy
Melanocyte Transfer Surgery
Combination Phototherapy + Topicals
Camouflage & Supportive Care
Your Vitiligo treatment timeline
Results are gradual, progressive, and lasting with the right protocol.
Watch: Vitiligo treatment at DermaVue
Our dermatologists explain diagnosis, treatment options, and what to expect.
Understanding Skin Conditions — Expert Dermatology Care
Frequently asked questions about Vitiligo
No, vitiligo is absolutely not contagious. It cannot spread through touch, sharing food, swimming together, or any form of physical contact. Vitiligo is an autoimmune condition where the body's own immune system attacks pigment-producing cells. The widespread misconception that vitiligo is contagious — sometimes wrongly linked to leprosy in Indian communities — has no medical basis whatsoever.
Vitiligo spreads when the autoimmune attack on melanocytes is active. Triggers for spreading include psychological stress, skin injuries (Koebner phenomenon), severe sunburn, and exposure to phenolic chemicals. Thyroid dysfunction, if untreated, can also drive disease activity. Oral mini-pulse corticosteroid therapy can arrest spread in 80–90% of cases within 3 months. Early dermatologist intervention during active spread is critical to limiting extent.
There is currently no permanent cure that eliminates the underlying autoimmune predisposition. However, significant repigmentation — often 70–90% colour restoration — is achievable with NB-UVB phototherapy, topical immunomodulators, and surgical melanocyte transfer in stable cases. Facial vitiligo responds best; acral areas (fingertips, toes) are most resistant. Maintenance therapy reduces relapse risk. Research into JAK inhibitors and targeted biologics is advancing rapidly.
DermaVue consultation fee is ₹300 at most branches. NB-UVB phototherapy session costs range from ₹500–1,500 per session depending on body area, with a typical course of 24–48 sessions. Excimer laser sessions range from ₹1,500–3,500 per session. Surgical melanocyte transfer costs depend on the area being treated and are discussed after stability assessment. All costs are explained transparently at your first consultation — no hidden charges.
Vitiligo itself does not affect physical health or life expectancy. However, it is associated with a higher incidence of other autoimmune conditions — particularly thyroid disorders (15–20% of patients), type 1 diabetes, and pernicious anaemia. DermaVue protocols include baseline and annual autoimmune screening to detect and manage any associated conditions early. The most significant health impact of vitiligo is psychological — depression, anxiety, and social withdrawal are common and addressed as part of comprehensive care.
Kerala's environment presents specific considerations: rubber plantation workers are exposed to phenolic compounds (para-tertiary-butylphenol) used in rubber processing, which can trigger chemical leukoderma. Intense tropical sun exposure without protection can cause sunburn that triggers Koebner phenomenon in predisposed individuals. Kerala also has a higher background prevalence of autoimmune thyroid disease, which is a known vitiligo co-morbidity. DermaVue dermatologists assess occupation, sun exposure patterns, and thyroid status as standard practice.
Stop managing Vitiligo.
Start clearing it.
Board-certified MD DVL dermatologists across 7 clinics in Kerala & Tamil Nadu. WhatsApp for instant appointment. Consultation ₹300.
₹300 consultation · No hidden charges · 7 locations